Novel IL-21 signaling pathway up-regulates c-Myc and induces apoptosis of diffuse large B-cell lymphomas.

Interleukin-21 (IL-21), a member of the IL-2 cytokine family, has diverse regulatory effects on natural killer (NK), T, and B cells. In contrast to other cytokines that are usually immunostimulatory, IL-21 can induce apoptosis of murine B cells at specific activation-differentiation stages. This effect may be used for treatment of B-cell malignancies. Herein we report that diffuse large B-cell lymphoma (DLBCL) cell lines exhibit widespread expression of the IL-21 receptor (IL-21R) and that IL-21 stimulation leads to cell-cycle arrest and caspase-dependent apoptosis. IL-21 also induces apoptosis in de novo DLBCL primary tumors but does not affect viability of human healthy B cells. Furthermore, IL-21 promotes tumor regression and prolongs survival of mice harboring xenograft DLBCL tumors. The antilymphoma effects of this cytokine are dependent on a mechanism involving IL-21-activated signal transducer and activator of transcription 3 (STAT3) up-regulating expression of c-Myc. This up-regulation promotes a decrease in expression of antiapoptotic Bcl-2 and Bcl-X(L) proteins triggering cell death. Our results represent one of the first examples in which the STAT3-c-Myc signaling pathway, which can promote survival and oncogenesis, can induce apoptosis in neoplastic cells. Moreover, based on IL-21's potency in vitro and in animal models, our findings indicate that this cytokine should be examined in clinical studies of DLBCL.

[1]  赤松 紀彦.  High IL-21 receptor expression and apoptosis induction by IL-21 in follicular lymphoma , 2009 .

[2]  P. Kristjansen,et al.  Clinical and Biological Efficacy of Recombinant Human Interleukin-21 in Patients with Stage IV Malignant Melanoma without Prior Treatment: A Phase IIa Trial , 2009, Clinical Cancer Research.

[3]  G. Evan,et al.  Distinct thresholds govern Myc's biological output in vivo. , 2008, Cancer cell.

[4]  I. Lossos,et al.  Interleukin-21 Induces Cell Cycle Arrest and Apoptosis of Diffuse Large B-Cell Lymphomas (DLBCL) Via Activation of STAT3 and Upregulation of C-Myc , 2008 .

[5]  R. Bataille,et al.  IL-21 Stimulates Human Myeloma Cell Growth through an Autocrine IGF-1 Loop , 2008, The Journal of Immunology.

[6]  M. Caligiuri,et al.  IL-21 mediates apoptosis through up-regulation of the BH3 family member BIM and enhances both direct and antibody-dependent cellular cytotoxicity in primary chronic lymphocytic leukemia cells in vitro. , 2008, Blood.

[7]  B. Redman,et al.  Phase I study of recombinant interleukin-21 in patients with metastatic melanoma and renal cell carcinoma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  G. Cattoretti,et al.  Constitutively activated STAT3 promotes cell proliferation and survival in the activated B-cell subtype of diffuse large B-cell lymphomas. , 2007, Blood.

[9]  I. Lossos,et al.  Optimization of RNA Extraction From Formalin-fixed, Paraffin-embedded Lymphoid Tissues , 2007, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[10]  Prim B. Singh,et al.  Interleukin-21: a new modulator of immunity, infection, and cancer. , 2007, Cytokine & growth factor reviews.

[11]  P. Lipsky,et al.  IL-21 and BAFF/BLyS synergize in stimulating plasma cell differentiation from a unique population of human splenic memory B cells. , 2007, Journal of immunology.

[12]  Mark J. Smyth,et al.  IL-21 Is Produced by NKT Cells and Modulates NKT Cell Activation and Cytokine Production1 , 2007, The Journal of Immunology.

[13]  J. Visvader,et al.  c‐myc as a mediator of accelerated apoptosis and involution in mammary glands lacking Socs3 , 2006, The EMBO journal.

[14]  S. Tangye,et al.  Kinetics of Human B Cell Behavior and Amplification of Proliferative Responses following Stimulation with IL-211 , 2006, The Journal of Immunology.

[15]  Bernd Jahrsdörfer,et al.  B-chronic lymphocytic leukemia cells and other B cells can produce granzyme B and gain cytotoxic potential after interleukin-21-based activation. , 2006, Blood.

[16]  M. Hatano,et al.  JunD/AP-1 and STAT3 are the major enhancer molecules for high Bcl6 expression in germinal center B cells. , 2006, International immunology.

[17]  M. Gobbi,et al.  Interleukin-21 receptor (IL-21R) is up-regulated by CD40 triggering and mediates proapoptotic signals in chronic lymphocytic leukemia B cells. , 2006, Blood.

[18]  G. Evan,et al.  Specific Requirement for Bax, Not Bak, in Myc-induced Apoptosis and Tumor Suppression in Vivo* , 2006, Journal of Biological Chemistry.

[19]  M. Colombo,et al.  CD25+ Regulatory T Cell Depletion Augments Immunotherapy of Micrometastases by an IL-21-Secreting Cellular Vaccine1 , 2006, The Journal of Immunology.

[20]  P. Lipsky,et al.  IL-21 Induces Differentiation of Human Naive and Memory B Cells into Antibody-Secreting Plasma Cells1 , 2005, The Journal of Immunology.

[21]  W. Leonard,et al.  Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiation , 2005, Nature Reviews Immunology.

[22]  Ash A. Alizadeh,et al.  Distinct IL-4-induced gene expression, proliferation, and intracellular signaling in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas. , 2005, Blood.

[23]  A. Stephanou,et al.  Opposing actions of STAT-1 and STAT-3 , 2005, Growth factors.

[24]  T. Lebien,et al.  Enhancement of stress-induced apoptosis in B-lineage cells by caspase-9 inhibitor. , 2004, Blood.

[25]  P. Lipsky,et al.  Regulation of B Cell Differentiation and Plasma Cell Generation by IL-21, a Novel Inducer of Blimp-1 and Bcl-61 , 2004, The Journal of Immunology.

[26]  T. Malek,et al.  Distinct Activation Signals Determine whether IL-21 Induces B Cell Costimulation, Growth Arrest, or Bim-Dependent Apoptosis1 , 2004, The Journal of Immunology.

[27]  S. Nutt,et al.  IL-21 Induces the Functional Maturation of Murine NK Cells 1 , 2004, The Journal of Immunology.

[28]  John L Cleveland,et al.  Myc pathways provoking cell suicide and cancer , 2003, Oncogene.

[29]  Anastasis Stephanou,et al.  STAT‐1: a novel regulator of apoptosis , 2003, International journal of experimental pathology.

[30]  Nicola Gebbia,et al.  STAT proteins: From normal control of cellular events to tumorigenesis , 2003, Journal of cellular physiology.

[31]  J. Cleveland,et al.  c-Myc Augments Gamma Irradiation-Induced Apoptosis by Suppressing Bcl-XL , 2003, Molecular and Cellular Biology.

[32]  K. Weinberg,et al.  The Common γ Chain (γc) Is a Required Signaling Component of the IL-21 Receptor and Supports IL-21-Induced Cell Proliferation via JAK3† , 2002 .

[33]  G. Evan,et al.  Suppression of Myc-Induced Apoptosis in β Cells Exposes Multiple Oncogenic Properties of Myc and Triggers Carcinogenic Progression , 2002, Cell.

[34]  M. Beal,et al.  Caspase-9 Activation Results in Downstream Caspase-8 Activation and Bid Cleavage in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Parkinson's Disease , 2001, The Journal of Neuroscience.

[35]  S. Korsmeyer,et al.  Bax Loss Impairs Myc-Induced Apoptosis and Circumvents the Selection of p53 Mutations during Myc-Mediated Lymphomagenesis , 2001, Molecular and Cellular Biology.

[36]  J. Cleveland,et al.  Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1 , 2001, Oncogene.

[37]  M. Roussel,et al.  Apoptosis Triggered by Myc-Induced Suppression of Bcl-XL or Bcl-2 Is Bypassed during Lymphomagenesis , 2001, Molecular and Cellular Biology.

[38]  T. Yeatman,et al.  Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[39]  John Calvin Reed,et al.  Bax is a transcriptional target and mediator of c-myc-induced apoptosis. , 2000, Cancer research.

[40]  Scott R. Presnell,et al.  Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function , 2000, Nature.

[41]  Kazuhito Yamamoto,et al.  BCL-2 Is Phosphorylated and Inactivated by an ASK1/Jun N-Terminal Protein Kinase Pathway Normally Activated at G2/M , 1999, Molecular and Cellular Biology.

[42]  J. Darnell,et al.  Stat3 as an Oncogene , 1999, Cell.

[43]  G. Prendergast,et al.  Mechanisms of apoptosis by c-Myc , 1999, Oncogene.

[44]  T. Hirano,et al.  Stat3 Is Required for the Gp130-mediated Full Activation of the C-myc Gene , 1999 .

[45]  S. Akira,et al.  STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[46]  M. Pallavicini,et al.  Relationship of c‐myc gene copy number and gene expression: Cellular effects of elevated c‐myc protein , 1990, Journal of cellular physiology.

[47]  D. Lipman,et al.  National Center for Biotechnology Information , 2019, Springer Reference Medizin.

[48]  K. Weinberg,et al.  The common gamma chain (gamma c) is a required signaling component of the IL-21 receptor and supports IL-21-induced cell proliferation via JAK3. , 2002, Biochemistry.